A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism
Karen J. Parker(Stanford University), Antonio Y. Hardan(Stanford University), Dean S. Carson(Stanford University), Noreen Mohsin(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Debra S. Karhson(Stanford University), Joseph P. Garner(Stanford University), Jennifer M. Phillips(Stanford University), Jacqueline E. Summers(Stanford University), Lawrence K. Fung(Stanford University), Kyle Hinman(Stanford University), Raena D. Sumiyoshi(Stanford University), Kara S. Motonaga(Stanford University), Robin A. Libove(Stanford University), Ozge Oztan(Stanford University)
Cited by 190
Related Papers
Salience Network–Based Classification and Prediction of Symptom Severity in Children With Autism
|JAMA Psychiatry|2013|630
Default Mode Network in Childhood Autism: Posteromedial Cortex Heterogeneity and Relationship with Social Deficits
|Biological Psychiatry|2013|370
Underconnectivity between voice-selective cortex and reward circuitry in children with autism
|Proceedings of the National Academy of Sciences|2013|258
Oxytocin receptor gene polymorphism (rs2254298) interacts with familial risk for psychopathology to predict symptoms of depression and anxiety in adolescent girls
|Psychoneuroendocrinology|2010|211
Brain Organization Underlying Superior Mathematical Abilities in Children with Autism
|Biological Psychiatry|2013|152